首页> 外文期刊>European archives of oto-rhino-laryngology: Official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) >Relationship between airborne pollen count and treatment outcome in Japanese cedar pollinosis patients.
【24h】

Relationship between airborne pollen count and treatment outcome in Japanese cedar pollinosis patients.

机译:日本雪松花粉病患者的空中花粉计数与治疗结果之间的关系。

获取原文
获取原文并翻译 | 示例
       

摘要

In Japan, information on daily Japanese cedar pollen counts is made public during pollen season. If symptom severity and treatment outcome are predictable according to these pollen counts, management of seasonal allergic rhinitis may become more precise. The aims of the study were to evaluate the relationship between airborne pollen counts, symptom severity and treatment outcome in Japanese cedar pollinosis patients. In the randomized study, patients with moderate to most severe Japanese pollinosis were treated with fexofenadine (60 mg BD) or fexofenadine and nasal corticosteroids for 2 weeks. During the same period daily airborne pollen counts were measured. A total of 105 adult patients were enrolled. No difference of treatment efficacy was seen among groups. Detailed results of efficacy and safety were previously described elsewhere. In univariate analysis, the mean cumulative amount of airborne pollen exposure for 4 days prior to the study tended to affect symptom severity (P = 0.053) and the mean cumulative amount of airborne pollen during the treatment period tended to show difference among five treatment outcome categories (P = 0.066). In multivariate analysis, the mean cumulative amount of airborne pollen exposure for 4 days prior to the study was identified as the only significant factor of symptom severity (P = 0.0327) and cumulative amount of airborne pollen during the treatment period (P = 0.027) and allergic history (P = 0.027) were significant factors of treatment outcomes. No serious adverse effect was reported during the study. The amount of airborne pollen may be predictive of both symptom severity and treatment outcome.
机译:在日本,在花粉季节会公开日本雪松每日花粉计数的信息。如果根据这些花粉计数可预测症状严重程度和治疗结果,则季节性变应性鼻炎的治疗可能会更加精确。该研究的目的是评估日本雪松花粉症患者的空中花粉计数,症状严重程度和治疗结果之间的关系。在随机研究中,中度至重度日本花粉症患者接受非索非那定(60 mg BD)或非索非那定和鼻用皮质类固醇激素治疗2周。在同一时期,每天测量空中花粉计数。共有105名成年患者入组。各组之间没有观察到治疗效果的差异。功效和安全性的详细结果先前已在其他地方进行了描述。在单变量分析中,研究前4天的空气中花粉的平均累积暴露量倾向于影响症状的严重程度(P = 0.053),并且在治疗期间,空气中花粉的平均累积积累量倾向于显示五种治疗结果类别之间的差异(P = 0.066)。在多变量分析中,研究前4天的空气中花粉累积平均暴露量被确定为症状严重程度(P = 0.0327)和治疗期间空气中花粉累积量(P = 0.027)的唯一重要因素,并且过敏史(P = 0.027)是治疗结果的重要因素。研究期间未报告严重不良反应。空气中花粉的量可以预测症状的严重程度和治疗效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号